Research suggests treating osteoporosis in SM requires a holistic approach
The treatment of bone disease associated with SM requires measures that target the mast cells that drive disease processes.
The treatment of bone disease associated with SM requires measures that target the mast cells that drive disease processes.
Always check the specific storage instructions for your medication.
Roughly 50% of people with SM have bone involvement.
If these symptoms appear suddenly, call emergency services.
Symptom diary is typically excellent at inducing memory recall in tracking disease evolution in SM.
Outcomes among patients with mast cell leukemia remain relatively poor.
18% of people with mastocytosis also have HαT.
A new study explores the diagnostic challenges posed by SM with an associated myeloid neoplasm (SM-AMN), an advanced form of SM.
Midostaurin is safe and effective in treating advanced systemic mastocytosis.
Depression is a mental health issue that should be taken seriously, as it can worsen over time if left untreated.